Literature DB >> 27664571

Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer.

Huizhong Li1, Jun Song2, Meng Cao2, Gang Wang1, Liantao Li1, Baofu Zhang1, Yang Li1, Wei Xu3, Junnian Zheng4.   

Abstract

Several combinations of inflammatory factors, including neutrophil-to- lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), have been reported to be prognostic factors in various malignant tumors, including colorectal cancer (CRC). The aim of this study was to evaluate the prognostic value of NLR and PLR for patients with rectal cancer (RC) who underwent curative surgery. Data from patients who underwent curative resection for RC were retrospectively reviewed. The cutoff for NLR and PLR was defined as 2.3 and 144 by receiver operating characteristic (ROC) curve. Overall survival (OS) and disease-free survival (DFS) were assessed using Kaplan-Meier method. Multivariable Cox regression model was used to evaluate the independent prognostic significance of variables. A total of 140 patients were eligible in the study. High NLR (>2.3) and high PLR (>144) both predicted lower OS and DFS according to Kaplan-Meier method. But in the multivariable Cox regression model, only the high NLR retained significance for reduced OS and DFS. According to Chi-square test, patients with higher NLR had larger tumor size and higher pN-stage. While PLR was only associated with the pN-stage. High preoperative NLR was shown to be a negative independent prognostic factor in patients undergoing resection for nonmetastatic RC. It may be helpful as a factor to guide the postoperative therapies.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Lymphocyte; Neutrophil; Platelet; Prognosis; Rectal cancer

Mesh:

Year:  2016        PMID: 27664571     DOI: 10.1016/j.intimp.2016.09.014

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

Review 1.  Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.

Authors:  Nan Chen; Wanling Li; Kexin Huang; Wenhao Yang; Lin Huang; Tianxin Cong; Qingfang Li; Meng Qiu
Journal:  Oncotarget       Date:  2017-05-09

2.  Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity.

Authors:  Hongyan Liu; Shishuo Sun; Gang Wang; Mengmeng Lu; Xiaokang Zhang; Xiaohuan Wei; Xiaoge Gao; Chao Huang; Zhen Li; Junnian Zheng; Qing Zhang
Journal:  Front Oncol       Date:  2021-04-19       Impact factor: 6.244

3.  The Significance of the preoperative lactate dehydrogenase/albumin Ratio in the Prognosis of Colon Cancer: a retrospective study.

Authors:  Zhihui Xie; Hui Zhou; Lei Wang; Yibo Wu
Journal:  PeerJ       Date:  2022-03-11       Impact factor: 2.984

4.  Predictive impact of the inflammation-based indices in colorectal cancer patients with adjuvant chemotherapy.

Authors:  Yong Tao; Lei Ding; Guan Gen Yang; Jian Ming Qiu; Dong Wang; Hongtao Wang; Chao Fu
Journal:  Cancer Med       Date:  2018-05-15       Impact factor: 4.452

Review 5.  Taiwan Society of Colon and Rectum Surgeons (TSCRS) Consensus for Anti-Inflammatory Nutritional Intervention in Colorectal Cancer.

Authors:  Cheng-Jen Ma; Wan-Hsiang Hu; Meng-Chuan Huang; Jy-Ming Chiang; Pao-Shiu Hsieh; Huann-Sheng Wang; Chien-Ling Chiang; Hui-Min Hsieh; Chou-Chen Chen; Jaw-Yuan Wang
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.